| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
7e-05 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
| mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.0001 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0002 |
| mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
0.0002 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |